---
title: SEQENS vs Sterling Pharma Solutions
slug_a: seqens
slug_b: sterlingpharmasolutions
site: cdmo
review_signal_gate: closed
canonical_path: /compare/seqens/sterlingpharmasolutions
---

# SEQENS vs Sterling Pharma Solutions

Side-by-side profile data from each company listing on this directory.

## SEQENS

- Profile: [/companies/seqens](/companies/seqens)

SEQENS — Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. The strongest documented coverage currently appears in locations (15).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- Flow Chemistry

## Sterling Pharma Solutions

- Profile: [/companies/sterlingpharmasolutions](/companies/sterlingpharmasolutions)

Sterling Pharma Solutions — Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.

Services: 15. Modalities: 3. Indications: 0. Locations: 14. Certifications: 18. The strongest documented coverage currently appears in certifications (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Peptide

### Development capabilities

- Analytical method development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Flow Chemistry